Pfizer’s vaccine for meningococcal disease gets FDA approval
HQ Team October 21, 2023: The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years.
Drugs
Health
Pharma